{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:08:14Z","timestamp":1772150894064,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T00:00:00Z","timestamp":1455840000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12872-016-0223-5","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T00:39:49Z","timestamp":1455842389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Inotropic agents use in patients hospitalized with acute decompensated heart failure: a retrospective analysis from a 22-year registry in a Middle-Eastern Country (1991\u20132013)"],"prefix":"10.1186","volume":"16","author":[{"given":"Amer H. S.","family":"Aljundi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaban F. K.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashfaq","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajvir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman","family":"Arabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajar A.","family":"AlBinali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jassim","family":"Al Suwaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,19]]},"reference":[{"key":"223_CR1","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1067\/mhj.2003.150","volume":"145","author":"GM Felker","year":"2003","unstructured":"Felker GM, Adams KF, Konstam MA, O\u2019Connor CM, Gheorghiade M. The problem of decompensated heart failure: Nomenclature, classification, and risk stratification. Am Heart J. 2003;145:S18\u201325.","journal-title":"Am Heart J"},{"key":"223_CR2","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/eurjhf\/hfp029","volume":"11","author":"F Najafi","year":"2009","unstructured":"Najafi F, Jamrozik K, Dobson AJ. Understanding the \u2018epidemic of heart failure\u2019: a systematic review of trends in determinants of heart failure. Eur J Heart Fail. 2009;11:472\u20139.","journal-title":"Eur J Heart Fail"},{"key":"223_CR3","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","volume":"123","author":"VL Roger","year":"2011","unstructured":"Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation. 2011;123:e18\u2013e209.","journal-title":"Circulation"},{"key":"223_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","volume":"149","author":"KF Adams","year":"2005","unstructured":"Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209\u201316.","journal-title":"Am Heart J"},{"key":"223_CR5","first-page":"510","volume":"36","author":"SM Joseph","year":"2009","unstructured":"Joseph SM, Cedars AM, Ewald GA, et al. Acute decompensated heart failure: contemporary medical management. Tex Heart Inst J. 2009;36:510\u201320.","journal-title":"Tex Heart Inst J"},{"key":"223_CR6","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1161\/CIRCULATIONAHA.105.590091","volume":"112","author":"M Gheorghiade","year":"2005","unstructured":"Gheorghiade M, Zannad F, Sopko G, Klein L, Pi\u00f1a IL, Konstam MA, et al. Acute heart failure syndromes: Current state and framework for future research. Circulation. 2005;112:3958\u201368.","journal-title":"Circulation"},{"key":"223_CR7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","volume":"53","author":"SA Hunt","year":"2009","unstructured":"Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update incorporated into the ACC\/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009;53:e1\u2013e90.","journal-title":"J Am Coll Cardiol"},{"key":"223_CR8","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","volume":"16","author":"J Lindenfeld","year":"2010","unstructured":"Heart Failure Society of America, Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, et al. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail. 2010;16:e1\u2013e194.","journal-title":"J Card Fail"},{"key":"223_CR9","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","volume":"10","author":"K Dickstein","year":"2008","unstructured":"Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, PooleWilson PA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10:933\u201389.","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"223_CR10","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","volume":"287","author":"MS Cuffe","year":"2002","unstructured":"Cuffe MS, Califf RM, Adams Jr KF, et al. Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIMECHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287(12):1541\u20137.","journal-title":"JAMA"},{"key":"223_CR11","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1067\/mhj.2002.125620","volume":"144","author":"AJ Burger","year":"2002","unstructured":"Burger AJ, Horton DP, LeJemtel T, et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J. 2002;144:1102\u20138.","journal-title":"Am Heart J"},{"key":"223_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","volume":"46","author":"WT Abraham","year":"2005","unstructured":"Abraham WT, Adams KF, Fonarow GC, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the acute decompensated heart failure national registry (ADHERE). J Am Coll Cardiol. 2005;46:57\u201364.","journal-title":"J Am Coll Cardiol"},{"issue":"4 Suppl A","key":"223_CR13","doi-asserted-by":"publisher","first-page":"6A","DOI":"10.1016\/0735-1097(93)90455-A","volume":"22","author":"KK Ho","year":"1993","unstructured":"Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993;22(4 Suppl A):6A\u201313A.","journal-title":"J Am Coll Cardiol"},{"key":"223_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ijcard.2003.06.018","volume":"96","author":"J Al Suwaidi","year":"2004","unstructured":"Al Suwaidi J, Bener A, Hajar HA, Numan MT. Does hospitalisation for congestive heart failure occur more frequently in Ramadan: a population- based study (1991\u20132001). Int J Cardiol. 2004;96:217\u201321.","journal-title":"Int J Cardiol"},{"issue":"2","key":"223_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/17482941.2012.655298","volume":"14","author":"J Al Suwaidi","year":"2012","unstructured":"Al Suwaidi J, Asaad N, Al-Qahtani A, Al-Mulla AW, Singh R, Albinali HA. Prevalence and outcome of Middle-eastern Arab and South Asian patients hospitalized with heart failure: insight from a 20-year registry in a Middle-eastern country (1991\u20132010). Acute Card Care. 2012;14(2):81\u20139.","journal-title":"Acute Card Care"},{"issue":"3","key":"223_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.amjcard.2011.09.026","volume":"109","author":"J Al Suwaidi","year":"2012","unstructured":"Al Suwaidi J, Al-Qahtani A, Asaad N, Al-Mulla AW, Singh R, Albinali HA. Comparison of women versus men hospitalized with heart failure (from a 20-year registry in a middle-eastern country 1991\u20132010). Am J Cardiol. 2012;109(3):395\u2013400.","journal-title":"Am J Cardiol"},{"key":"223_CR17","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","volume":"285","author":"PA McKee","year":"1971","unstructured":"McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham Study. N Engl J Med. 1971;285:1441\u20136.","journal-title":"N Engl J Med"},{"key":"223_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","volume":"47","author":"CW Yancy","year":"2006","unstructured":"Yancy CW, Lopatin M, Stevenson LW, et al. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) database. J Am Coll Cardiol. 2006;47:76\u201384.","journal-title":"J Am Coll Cardiol"},{"issue":"suppl 7","key":"223_CR19","first-page":"S21","volume":"4","author":"GC Fonarow","year":"2003","unstructured":"Fonarow GC, for the ADHERE Scientific Advisory Committee. The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med. 2003;4 suppl 7:S21\u201330.","journal-title":"Rev Cardiovasc Med"},{"key":"223_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1054\/jcaf.2001.24131","volume":"7","author":"MR Shah","year":"2001","unstructured":"Shah MR, Hasselblad V, Stinnett SS, et al. Hemodynamic profiles of advanced heart failure: Association with clinical characteristics and long-term outcomes. J Card Fail. 2001;7:105\u201313.","journal-title":"J Card Fail"},{"key":"223_CR21","doi-asserted-by":"publisher","first-page":"S293","DOI":"10.1016\/S0002-8703(98)70257-1","volume":"135","author":"LW Stevenson","year":"1998","unstructured":"Stevenson LW, Massie BM, Francis GS. Optimizing therapy for complex or refractory heart failure: A management algorithm. Am Heart J. 1998;135:S293\u2013309.","journal-title":"Am Heart J"},{"key":"223_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jacc.2003.07.031","volume":"43","author":"DE Forman","year":"2004","unstructured":"Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43:61\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"223_CR23","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.jacc.2005.03.028","volume":"45","author":"LW Stevenson","year":"2005","unstructured":"Stevenson LW, Nohria A, Mielniczuk L. Torrent or torment from the tubules? Challenge of the cardiorenal connections. J Am Coll Cardiol. 2005;45:2004\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"223_CR24","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S0195-668X(02)00823-0","volume":"24","author":"JGF Cleland","year":"2003","unstructured":"Cleland JGF, Swedberg K, Follath F, et al. The EuroHeart Failure survey programme\u2014A survey on the quality of care among patients with heart failure in Europe: Part 1: Patient characteristics and diagnosis. Eur Heart J. 2003;24:442\u201363.","journal-title":"Eur Heart J"},{"key":"223_CR25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1056\/NEJM197410032911405","volume":"291","author":"LI Goldberg","year":"1974","unstructured":"Goldberg LI. Dopamine: clinical uses of an endogenous catecholamine. N Engl J Med. 1974;291:707\u201310.","journal-title":"N Engl J Med"},{"issue":"8","key":"223_CR26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0146-2806(96)80002-8","volume":"21","author":"CV Leier","year":"1996","unstructured":"Leier CV. Positive inotropic therapy: an update and new agents. Curr Probl Cardiol. 1996;21(8):521\u201381.","journal-title":"Curr Probl Cardiol"},{"key":"223_CR27","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S0735-1097(02)02968-6","volume":"41","author":"GM Felker","year":"2003","unstructured":"Felker GM, Benza RL, Chandler AB, et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J Am Coll Cardiol. 2003;41:997\u20131003.","journal-title":"J Am Coll Cardiol"},{"issue":"2 Pt 2","key":"223_CR28","first-page":"78S","volume":"16","author":"JB Young","year":"1996","unstructured":"Young JB. Evolv ing concepts in the treatment of heart failure: should new inotropic agents carry promise or paranoia? Pharmacotherapy. 1996;16(2 Pt 2):78S\u201384S.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"223_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/BF00050911","volume":"6","author":"S Sasayama","year":"1992","unstructured":"Sasayama S. What do the newer inotropic drugs have to offer? Cardiovasc Drugs Ther Feb. 1992;6(1):15.","journal-title":"Cardiovasc Drugs Ther Feb"},{"key":"223_CR30","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","volume":"325","author":"M Packer","year":"1991","unstructured":"Packer M, Carver JR, Rodeheffer RJ, et al. Effect of Oral Milrinone on mortality in severe chronic heart failure. N Engl J Med. 1991;325:1468\u201375.","journal-title":"N Engl J Med"},{"issue":"Suppl IV","key":"223_CR31","first-page":"55","volume":"75","author":"M Packer","year":"1987","unstructured":"Packer M, Leir CV. Survival in congestive heart failure during treatment with drugs with positive inotropic actions. Circulation. 1987;75(Suppl IV):55\u201363.","journal-title":"Circulation"},{"key":"223_CR32","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0009-9236(98)90092-3","volume":"63","author":"A Elis","year":"1998","unstructured":"Elis A, Bental T, Kimchi O, et al. Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study. Clin Pharmacol Ther. 1998;63:682\u20135.","journal-title":"Clin Pharmacol Ther"},{"key":"223_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0002-8703(99)70108-0","volume":"138","author":"F Oliva","year":"1999","unstructured":"Oliva F, Latini R, Politi A, et al. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial. Am Heart J. 1999;138:247\u201353.","journal-title":"Am Heart J"},{"key":"223_CR34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0002-8703(99)70250-4","volume":"138","author":"CM O\u2019Connor","year":"1999","unstructured":"O\u2019Connor CM, Gattis WA, Uretsky BF, et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J. 1999;138:78\u201386.","journal-title":"Am Heart J"},{"key":"223_CR35","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.ejheart.2004.07.007","volume":"6","author":"AP Coletta","year":"2004","unstructured":"Coletta AP, Cleland JG, Freemantle N, et al. Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy. Eur J Heart Fail. 2004;6:673\u20136.","journal-title":"Eur J Heart Fail"},{"key":"223_CR36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ejheart.2004.04.014","volume":"6","author":"JG Cleland","year":"2004","unstructured":"Cleland JG, Ghosh J, Freemantle N, et al. Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail. 2004;6:501\u20138.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"223_CR37","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S1388-9842(02)00041-7","volume":"4","author":"S Thackray","year":"2002","unstructured":"Thackray S, Easthaugh J, Freemantle N, et al. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis. Eur J Heart Fail. 2002;4(4):515\u201329.","journal-title":"Eur J Heart Fail"},{"key":"223_CR38","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S0735-1097(01)01818-6","volume":"39","author":"MA Silver","year":"2002","unstructured":"Silver MA, Horton DP, Ghali JK, et al. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol. 2002;39:798\u2013803.","journal-title":"J Am Coll Cardiol"},{"key":"223_CR39","first-page":"5","volume":"7","author":"PW Pflugfelder","year":"1991","unstructured":"Pflugfelder PW, O\u2019Neill BJ, Ogilvie RI, et al. A Canadian multicentre study of a 48\u00a0h infusion of milrinone in patients with severe heart failure. Can J Cardiol. 1991;7:5\u201310.","journal-title":"Can J Cardiol"},{"key":"223_CR40","doi-asserted-by":"publisher","unstructured":"Reassessing treatment of acute heart failure syndromes: the ADHERE Registry Mihai Gheorghiade1* and Gerasimos Filippatos2 European Heart Journal Supplements (2005) 7 (Supplement B), B13\u2013B19. doi:\n                    10.1093\/eurheartj\/sui008","DOI":"10.1093\/eurheartj\/sui008"},{"issue":"8","key":"223_CR41","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/S0735-1097(03)01058-1","volume":"42","author":"D Johnson","year":"2003","unstructured":"Johnson D, Jin Y, Quan H, Cujec B. Beta-blockers and angiotensinconverting enzyme inhibitors\/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada. J Am Coll Cardiol. 2003;42(8):1438\u201345.","journal-title":"J Am Coll Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0223-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-016-0223-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0223-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0223-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T22:52:45Z","timestamp":1506120765000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-016-0223-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,19]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["223"],"URL":"https:\/\/doi.org\/10.1186\/s12872-016-0223-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,19]]},"article-number":"47"}}